
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 13 September 2022
Sec. Pharmacology of Anti-Cancer Drugs
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1027056
This article is a correction to:
The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset
A Corrigendum on
The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell rna sequencing dataset
By Liu W, Hao Y, Tian X, Jiang J and Qiu Q (2022) Front. Oncol. 12:879288. doi: 10.3389/fonc.2022.879288
In the published article, there was an error in the affiliations list for author Jing Jiang. Instead of “Department of Spine Surgery, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China”, it should be “Department of Clinical Laboratory, Nanchang Medical College, Nanchang, China”.
In the published article, there was an error in the affiliations list for author Quanhe Qiu. Instead of “Department of Orthopedic, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huaian, China”, it should be “Department of Spine Surgery, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, China”.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: osteosarcoma, scRNA-seq, tumor microenvironment, metastasis, recurrent, nuclear receptor
Citation: Liu W, Hao Y, Tian X, Jiang J and Qiu Q (2022) Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset. Front. Oncol. 12:1027056. doi: 10.3389/fonc.2022.1027056
Received: 24 August 2022; Accepted: 26 August 2022;
Published: 13 September 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Liu, Hao, Tian, Jiang and Qiu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Quanhe Qiu, cWl1aGVpbWFAMTYzLmNvbQ==; Jing Jiang, amlhbmdqaW5nNjEyQDE2My5jb20=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.